The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Subscribe To Our Newsletter & Stay Updated